Related Experiment Video
Updated: Dec 28, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis Transmission or Mortality Among Persons Living with HIV, USA, 2011-2016
K M Schmit1, N Shah2, S Kammerer2
1Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Mailstop US12-4, 1600 Clifton Road, Atlanta, GA, 30329, USA. kmschmit@cdc.gov.
People with HIV and tuberculosis (TB) face higher risks of recent TB transmission and death during treatment. Interventions should target high-risk groups, and directly observed treatment (DOT) can reduce mortality.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Individuals with HIV are at increased risk for tuberculosis (TB) disease due to recent transmission (RT) and mortality during TB treatment.
- Understanding factors associated with RT and mortality in TB/HIV patients is crucial for effective public health interventions.
Purpose of the Study:
- To examine patient characteristics associated with recent TB transmission (RT) and mortality among TB/HIV patients.
- To identify risk factors and protective measures for improving outcomes in this vulnerable population.
Main Methods:
- Utilized National TB Surveillance System data from 2011 to 2016.
- Employed multivariable adjusted odds ratios (aOR) with 99% confidence intervals (CI) to assess associations between patient characteristics and RT or mortality.
- Mortality analyses were restricted to 2011-2014 to ensure adequate outcome reporting time.
Main Results:
- Recent TB transmission (RT) occurred in 20% of TB/HIV patients, with higher likelihoods among those reporting homelessness, substance use, and among Black and Hispanic individuals.
- RT was less common in non-US-born individuals.
- Mortality during TB treatment was higher in TB/HIV patients (8.6%) compared to those without HIV (5.2%).
- Factors associated with increased mortality included age (≥65 years and 45-64 years) and co-existing medical risk factors for TB.
- Directly observed treatment (DOT) for TB demonstrated a protective effect against mortality.
Conclusions:
- Prioritize interventions for Black, Hispanic, and homeless or substance-using TB/HIV patients to reduce TB transmission.
- Directly observed treatment (DOT) improves adherence and reduces mortality.
- Additional strategies are needed to decrease mortality among older TB/HIV patients and those with other medical risk factors.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Sexually Transmitted Infections
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: